Tradestie Institutional Equity Comparison Engine

EHC vs CHE โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EHC Overall Edge

EHC Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Encompass Health Corporation Common Stock (EHC) driven by superior Valuation, Options & Structure while CHE counters with relative strength in Growth & Margin, Momentum & Technical. Fundamentally, EHC trades at 19.4x Forward P/E with 18.4% operating margin (+8.9% YoY revenue) versus CHE at 19.7x Forward P/E and 14.3% operating margin (+10.6% YoY). In options structure, EHC sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro) against CHE sits in UNCLASSIFIED (10th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner EHC
EHC 19.4x vs CHE 19.7x Fwd P/E
Growth & Margin Winner CHE
Op Margin 18.4% vs 14.3% ยท YoY +8.9% vs +10.6%
Momentum & Technical Winner CHE
1Y +19.4% vs +27.6% ยท 52W Pos 80% vs 93%
Options & Structure Winner EHC
CONSOLIDATION (8th %ile IV) vs UNCLASSIFIED (10th %ile IV)
EHC NYSE
Encompass Health Corporation Common Stock
Services-Hospitals
$133.65
+1.04% 1D
Market Cap $13.0B
1M Return +6.06%
1Y Return +19.42%
Forward P/E 19.4x
Unified AI Score
52.0 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 54.0 Mom 50.0
CHE NYSE
Chemed Corporation
Services-Home Health Care Services
$548.59
-0.5% 1D
Market Cap $7.1B
1M Return +5.47%
1Y Return +27.64%
Forward P/E 19.7x
Unified AI Score
43.8 / 100 HOLD
Tech 35.0 Fund 44.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EHC +19.42% CHE +27.64% Spread: +8.22 pp (CHE Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
EHC TTM Op. Margin: 18.4% CHE TTM Op. Margin: 14.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EHC vs CHE. Trailing 12-month operating profitability (EHC 18.4% vs CHE 14.3%) and valuation multiples (EHC 19.4x vs CHE 19.7x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EHC (5) vs CHE (5)
Institutional Metric EHC CHE Criterion Row Winner
Market Capitalization Scale $13.0B $7.1B Larger Scale EHC
Trailing P/E Ratio Valuation 21.2x 26.4x Lower Multiple EHC
Forward P/E Ratio Valuation 19.4x 19.7x Lower Multiple EHC
Revenue Growth (YoY) Growth +8.9% +10.6% Higher Growth CHE
Operating Margin (TTM) Profitability 18.4% 14.3% Higher Margin EHC
Net Profit Margin Profitability 10.2% 10.6% Higher Margin CHE
Return on Equity (ROE) Capital Efficiency 25.1% 29.1% Higher ROE CHE
52-Week Range Position Momentum 80% ($93โ€“$144) 93% ($365โ€“$562) Stronger Trend CHE
Beta / 30D Volatility Risk Regime -0.10ฮฒ ยท 40% Vol 0.11ฮฒ ยท 26% Vol Lower Realized Risk CHE
Unified Institutional Score Composite Signal 52.0 / 100 (HOLD) 43.8 / 100 (HOLD) Higher Composite EHC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EHC vs CHE Buy Guide
EHC CONSOLIDATION
73d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live EHC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CHE UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live CHE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EHC nor CHE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.